Sunday, May 11, 2014 3:39:45 PM
- No significant revenue for years.
- A multi-year history of PR's claiming a constant stream of new distribution agreements all over the world, yet still no significant revenues.
- Repeated dilution.
- A loss in share value of over 98% since 2009.
- Repeated denials by the FDA including to DeNovo applications.
- Claims by management they are "waiting by the fax machine for FDA approval at any moment" (their words, not mine), approval which never materializes.
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
